Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 309
6
Diseases
256
Unique genes
0.134
Avg. similarity score
Graves disease
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Graves disease
Thyroid disease
Hashimoto disease
Hyperthyroidism
Vitiligo
Charcot-Marie-Tooth disease, demyelinating, type 1J
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Graves disease | 5 | 5 | 99 |
| Thyroid disease | 4 | 4 | 53 |
| Hashimoto disease | 3 | 3 | 27 |
| Hyperthyroidism | 3 | 3 | 53 |
| Vitiligo | 3 | 3 | 126 |
| Charcot-Marie-Tooth disease, demyelinating, type 1J | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BACH2 | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| CTLA4 | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| HLA-DQA1 | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| ICOS | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| IL2RA | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| LPP | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| PTPN22 | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| TG | 5 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
| FAM76B | 4 / 6 | Graves disease, Hashimoto disease, Thyroid disease, Vitiligo |
| HLA-DQB1 | 4 / 6 | Graves disease, Hyperthyroidism, Thyroid disease, Vitiligo |
| HLA-DRB1 | 4 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Vitiligo |
| RNASET2 | 4 / 6 | Graves disease, Hyperthyroidism, Thyroid disease, Vitiligo |
| STAT4 | 4 / 6 | Graves disease, Hashimoto disease, Thyroid disease, Vitiligo |
| VAV3 | 4 / 6 | Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease |
| ARID5B | 3 / 6 | Graves disease, Thyroid disease, Vitiligo |
| ATXN2 | 3 / 6 | Hashimoto disease, Thyroid disease, Vitiligo |
| C1QTNF6 | 3 / 6 | Graves disease, Thyroid disease, Vitiligo |
| CCR6 | 3 / 6 | Graves disease, Thyroid disease, Vitiligo |
| ITPR3 | 3 / 6 | Charcot-Marie-Tooth disease, demyelinating, type 1J, Graves disease, Vitiligo |
| PDE8B | 3 / 6 | Hashimoto disease, Hyperthyroidism, Thyroid disease |
| PHTF1 | 3 / 6 | Hyperthyroidism, Thyroid disease, Vitiligo |
| RSBN1 | 3 / 6 | Hyperthyroidism, Thyroid disease, Vitiligo |
| SH2B3 | 3 / 6 | Hashimoto disease, Thyroid disease, Vitiligo |
| TNF | 3 / 6 | Graves disease, Hyperthyroidism, Vitiligo |
| VEGFA | 3 / 6 | Graves disease, Hyperthyroidism, Thyroid disease |
| BTNL2 | 2 / 6 | Graves disease, Vitiligo |
| C4A | 2 / 6 | Graves disease, Vitiligo |
| CAT | 2 / 6 | Hyperthyroidism, Vitiligo |
| CD69 | 2 / 6 | Hashimoto disease, Thyroid disease |
| CEP43 | 2 / 6 | Graves disease, Thyroid disease |
| CLNK | 2 / 6 | Thyroid disease, Vitiligo |
| FAM227B | 2 / 6 | Hyperthyroidism, Thyroid disease |
| FCRL3 | 2 / 6 | Graves disease, Thyroid disease |
| IFIH1 | 2 / 6 | Graves disease, Vitiligo |
| IFNG | 2 / 6 | Graves disease, Vitiligo |
| IL6 | 2 / 6 | Graves disease, Hashimoto disease |
| IL6R | 2 / 6 | Graves disease, Hashimoto disease |
| MICOS10 | 2 / 6 | Hyperthyroidism, Thyroid disease |
| MMEL1 | 2 / 6 | Graves disease, Hashimoto disease |
| MUC22 | 2 / 6 | Graves disease, Hyperthyroidism |
| NEK6 | 2 / 6 | Thyroid disease, Vitiligo |
| NFIA | 2 / 6 | Hyperthyroidism, Thyroid disease |
| PDE10A | 2 / 6 | Hyperthyroidism, Thyroid disease |
| PRICKLE1 | 2 / 6 | Graves disease, Hashimoto disease |
| PRSS36 | 2 / 6 | Graves disease, Hashimoto disease |
| PTPRC | 2 / 6 | Hyperthyroidism, Vitiligo |
| RHOH | 2 / 6 | Graves disease, Vitiligo |
| SLC25A27 | 2 / 6 | Graves disease, Hashimoto disease |
| SOD2 | 2 / 6 | Hyperthyroidism, Vitiligo |
| TNFRSF8 | 2 / 6 | Graves disease, Hashimoto disease |
| TNFSF8 | 2 / 6 | Graves disease, Hashimoto disease |
| TPO | 2 / 6 | Graves disease, Thyroid disease |
| TSBP1 | 2 / 6 | Graves disease, Hyperthyroidism |
| TSHR | 2 / 6 | Graves disease, Hyperthyroidism |
| UBASH3A | 2 / 6 | Graves disease, Vitiligo |
| VDR | 2 / 6 | Graves disease, Vitiligo |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Autoimmune thyroid disease | KEGG | 24 / 54 | 20.9× | 2.08e-26 | 4.42e-23 ✓ sig. |
| Allograft rejection | KEGG | 21 / 39 | 25.3× | 1.55e-25 | 2.96e-22 ✓ sig. |
| Inflammatory bowel disease | KEGG | 25 / 66 | 17.8× | 2.45e-25 | 4.51e-22 ✓ sig. |
| Type I diabetes mellitus | KEGG | 20 / 44 | 21.3× | 1.99e-22 | 2.47e-19 ✓ sig. |
| Graft-versus-host disease | KEGG | 20 / 45 | 20.9× | 3.51e-22 | 4.22e-19 ✓ sig. |
| Rheumatoid arthritis | KEGG | 25 / 95 | 12.3× | 7.54e-21 | 6.83e-18 ✓ sig. |
| Asthma | KEGG | 15 / 32 | 22.0× | 2.32e-17 | 1.17e-14 ✓ sig. |
| Th17 cell differentiation | KEGG | 23 / 109 | 9.9× | 6.11e-17 | 2.87e-14 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 17 / 50 | 16.0× | 1.20e-16 | 5.31e-14 ✓ sig. |
| Herpes simplex virus 1 infection | KEGG | 25 / 182 | 6.4× | 9.61e-14 | 2.48e-11 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 20 / 108 | 8.7× | 9.85e-14 | 2.53e-11 ✓ sig. |
| Phosphorylation of CD3 and TCR zeta chains | Reactome | 11 / 22 | 23.5× | 1.91e-13 | 4.60e-11 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 19 / 100 | 8.9× | 2.56e-13 | 6.08e-11 ✓ sig. |
| Leishmaniasis | KEGG | 17 / 78 | 10.2× | 4.47e-13 | 1.03e-10 ✓ sig. |
| Translocation of ZAP-70 to Immunological synapse | Reactome | 10 / 19 | 24.7× | 1.27e-12 | 2.72e-10 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| immune response | GO:0006955 | 43 / 543 | 5.8× | 7.61e-21 | 1.39e-17 ✓ sig. |
| antigen processing and presentation | GO:0019882 | 12 / 48 | 18.2× | 1.52e-12 | 6.69e-10 ✓ sig. |
| positive regulation of T cell proliferation | GO:0042102 | 13 / 67 | 14.2× | 5.80e-12 | 2.25e-9 ✓ sig. |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | GO:0002504 | 8 / 15 | 38.9× | 6.59e-12 | 2.53e-9 ✓ sig. |
| peptide antigen assembly with MHC class II protein complex | GO:0002503 | 8 / 16 | 36.5× | 1.30e-11 | 4.67e-9 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 11 / 45 | 17.8× | 1.73e-11 | 6.01e-9 ✓ sig. |
| immune system process | GO:0002376 | 41 / 943 | 3.2× | 4.72e-11 | 1.46e-8 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 20 / 232 | 6.3× | 7.04e-11 | 2.09e-8 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 17 / 161 | 7.7× | 8.22e-11 | 2.39e-8 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 46 / 1,208 | 2.8× | 2.23e-10 | 5.89e-8 ✓ sig. |
| positive regulation of B cell proliferation | GO:0030890 | 10 / 47 | 15.5× | 6.48e-10 | 1.53e-7 ✓ sig. |
| positive regulation of smooth muscle cell proliferation | GO:0048661 | 10 / 52 | 14.0× | 1.86e-9 | 3.89e-7 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 18 / 224 | 5.9× | 2.01e-9 | 4.15e-7 ✓ sig. |
| positive regulation of osteoclast differentiation | GO:0045672 | 8 / 28 | 20.9× | 2.73e-9 | 5.43e-7 ✓ sig. |
| antigen processing and presentation of exogenous peptide antigen via MHC class II | GO:0019886 | 8 / 31 | 18.8× | 6.68e-9 | 1.21e-6 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Graves disease | Hashimoto disease | 0.187 | 20 | 1.61e-39 | 7.04e-38 ✓ sig. |
| Hyperthyroidism | Thyroid disease | 0.216 | 19 | 4.45e-35 | 1.70e-33 ✓ sig. |
| Hashimoto disease | Thyroid disease | 0.227 | 15 | 2.15e-31 | 7.25e-30 ✓ sig. |
| Graves disease | Thyroid disease | 0.150 | 20 | 3.24e-31 | 1.09e-29 ✓ sig. |
| Graves disease | Vitiligo | 0.124 | 25 | 6.00e-31 | 1.99e-29 ✓ sig. |
| Thyroid disease | Vitiligo | 0.132 | 21 | 6.63e-31 | 2.19e-29 ✓ sig. |
| Graves disease | Hyperthyroidism | 0.125 | 17 | 3.47e-25 | 9.04e-24 ✓ sig. |
| Hashimoto disease | Hyperthyroidism | 0.157 | 11 | 3.32e-21 | 7.04e-20 ✓ sig. |
| Charcot-Marie-Tooth disease, demyelinating, type 1J | Graves disease | 0.010 | 1 | 6.43e-3 | 7.69e-3 ✓ sig. |
| Charcot-Marie-Tooth disease, demyelinating, type 1J | Vitiligo | 0.008 | 1 | 8.18e-3 | 9.49e-3 ✓ sig. |